Catalyst Pharmaceuticals Inc (CPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CPRX? Forum Prognose

Finanzdaten der Catalyst Pharmaceuticals Inc-Aktie (CPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.64% 146.56	141.42	141.82	128.69	122.71
Cost Of Revenue	15.09% 20.61	17.91	21.64	19.28	15.40
Gross Profit	1.97% 125.95	123.51	120.18	109.42	107.31
Operating Expenses	0.97% 50.31	50.80	19.96	58.51	53.06
Benefits Costs and Expenses	10.17% 77.27	70.14	67.64	71.49	66.92
Costs And Expenses	10.17% 77.27	70.14	67.64	71.49	66.92
Operating Income/Loss	4.63% 66.30	63.37	62.84	50.91	54.25
Income/Loss From Continuing Operations Before Tax	2.80% 69.29	71.29	74.18	57.20	55.79
Income Tax Expense/Benefit	18.12% 17.18	14.55	18.25	13.32	14.99
Income/Loss From Continuing Operations After Tax	8.16% 52.11	56.74	55.94	43.88	40.79
Net Income/Loss	8.16% 52.11	56.74	55.94	43.88	40.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.57% 122.16	121.47	0.4816	118.93	118.18
Diluted Average Shares	0.46% 127.54	126.96	0.4238	125.41	124.66
Basic Earnings Per Share	8.51% 0.43	0.47	0.46	0.37	0.35
Diluted Earnings Per Share	8.89% 0.41	0.45	0.44	0.35	0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%